Astria Therapeutics
ATXS
ATXS
76 hedge funds and large institutions have $205M invested in Astria Therapeutics in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more call options, than puts
Call options by funds: $188K | Put options by funds: $187K
34% less capital invested
Capital invested by funds: $312M → $205M (-$106M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
76
Holding in Top 10
1
Calls
$188K
Puts
$187K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$4.47M | |
| 3 | +$3.37M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.95M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.64M |
Top Sellers
| 1 | -$6.46M | |
| 2 | -$4.17M | |
| 3 | -$2.42M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.13M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.73M |